These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1250 related items for PubMed ID: 16864058

  • 1. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM, KIR Study Group, Center for International Blood and Marrow Transplantation Research.
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [Abstract] [Full Text] [Related]

  • 2. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E, International Histocompatibility Working Group.
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
    [Abstract] [Full Text] [Related]

  • 3. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y, Japan Marrow Donor Program.
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [Abstract] [Full Text] [Related]

  • 4. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R, Ruggeri A, Purtill D, Rodrigues CA, Gluckman E, Rocha V, Eurocord and of the European Group of Blood and Marrow Transplantation.
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [Abstract] [Full Text] [Related]

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 6. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH.
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [Abstract] [Full Text] [Related]

  • 7. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
    Chen C, Busson M, Rocha V, Appert ML, Lepage V, Dulphy N, Haas P, Socié G, Toubert A, Charron D, Loiseau P.
    Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
    [Abstract] [Full Text] [Related]

  • 8. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.
    N Engl J Med; 2004 Nov 25; 351(22):2265-75. PubMed ID: 15564543
    [Abstract] [Full Text] [Related]

  • 9. Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.
    Sivula J, Volin L, Porkka K, Vettenranta K, Itälä M, Partanen J, Turpeinen H.
    Transpl Immunol; 2007 Jul 25; 18(1):62-6. PubMed ID: 17584604
    [Abstract] [Full Text] [Related]

  • 10. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
    De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, Christiansen FT.
    Tissue Antigens; 2005 Jun 25; 65(6):519-28. PubMed ID: 15896199
    [Abstract] [Full Text] [Related]

  • 11. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C, ARS2000 FRM and FGM group.
    Biol Blood Marrow Transplant; 2009 Nov 25; 15(11):1366-75. PubMed ID: 19822295
    [Abstract] [Full Text] [Related]

  • 12. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
    Yabe T, Matsuo K, Hirayasu K, Kashiwase K, Kawamura-Ishii S, Tanaka H, Ogawa A, Takanashi M, Satake M, Nakajima K, Tokunaga K, Inoko H, Saji H, Ogawa S, Juji T, Sasazuki T, Kodera Y, Morishima Y, Japan Marrow Donor Program.
    Biol Blood Marrow Transplant; 2008 Jan 25; 14(1):75-87. PubMed ID: 18158964
    [Abstract] [Full Text] [Related]

  • 13. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A.
    Bone Marrow Transplant; 1997 Jul 25; 20(1):11-9. PubMed ID: 9232250
    [Abstract] [Full Text] [Related]

  • 14. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.
    Tissue Antigens; 2007 Apr 25; 69 Suppl 1():42-5. PubMed ID: 17445161
    [Abstract] [Full Text] [Related]

  • 15. Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.
    Gagne K, Busson M, Balere-Appert ML, Absi L, Jollet I, Bignon JD, Bois M, Dormoy A, Dubois V, Gebuhrer L, Loiseau P, Masson D, Moine A, Perrier P, Reviron D, Charron D, Raffoux C, ARS 2000 FRM and FGM group.
    Tissue Antigens; 2007 Apr 25; 69 Suppl 1():118-22. PubMed ID: 17445183
    [Abstract] [Full Text] [Related]

  • 16. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
    Ludajic K, Balavarca Y, Bickeböller H, Rosenmayr A, Fae I, Fischer GF, Kouba M, Pohlreich D, Kalhs P, Greinix HT.
    Bone Marrow Transplant; 2009 Jul 25; 44(2):97-103. PubMed ID: 19169284
    [Abstract] [Full Text] [Related]

  • 17. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR, Olerup O, Ljungman P, Remberger M.
    Biol Blood Marrow Transplant; 2004 Feb 25; 10(2):128-34. PubMed ID: 14750078
    [Abstract] [Full Text] [Related]

  • 18. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.
    Biol Blood Marrow Transplant; 2010 Feb 25; 16(2):273-80. PubMed ID: 19857587
    [Abstract] [Full Text] [Related]

  • 19. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 25; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 20. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D, Schaffer M, Ringdén O, Hassan Z, Omazic B, Mattsson J, Wikström AC, Remberger M.
    Tissue Antigens; 2008 Dec 25; 72(6):549-58. PubMed ID: 19000143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.